Tonix Pharmaceuticals Holding CORP. 8-K Filing
Ticker: TNXP · Form: 8-K · Filed: Nov 18, 2025 · CIK: 1430306
Sentiment: neutral
Filing Stats: 643 words · 3 min read · ~2 pages · Grade level 14.3 · Accepted 2025-11-18 17:21:25
Key Financial Figures
- $25.0 million — pany may repurchase up to an additional $25.0 million in value of its outstanding common stoc
- $35 million — authorized shares under the program to $35 million. Forward-Looking Statements This Cur
Filing Documents
- tnxp-8k_111825.htm (8-K) — 23KB
- 0001999371-25-018108.txt ( ) — 182KB
- tnxp-20251118.xsd (EX-101.SCH) — 3KB
- tnxp-20251118_lab.xml (EX-101.LAB) — 33KB
- tnxp-20251118_pre.xml (EX-101.PRE) — 22KB
- tnxp-8k_111825_htm.xml (XML) — 3KB
01. Other Events
Item 8.01. Other Events. On November 18, 2025, Tonix Pharmaceuticals Holding Corp.'s (the "Company") Board of Directors approved an increase to its share repurchase program pursuant to which the Company may repurchase up to an additional $25.0 million in value of its outstanding common stock, bringing total authorized shares under the program to $35 million.
Forward-Looking Statements
Forward-Looking Statements This Current Report on Form 8-K contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and Private Securities Litigation Reform Act, as amended, including those relating to the Company's product development, clinical trials, clinical and regulatory timelines, market opportunity, competitive position, possible or assumed future results of operations, business strategies, potential growth opportunities and other statement that are predictive in nature. These forward-looking and management's current beliefs and assumptions. These statements may be identified by the use of forward-looking expressions, including, but not limited to, "expect," "anticipate," "intend," "plan," "believe," "estimate," "potential," "predict," "project," "should," "would" and similar expressions and the negatives of those terms. These statements relate to future events or our financial performance and involve known and unknown risks, uncertainties, and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include those set forth in the Company's filings with the SEC. Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. SIGNATURE Pursuant to the requirement of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authoriz